Glistening and IOLs

The influence of glistenings (small - 1.0 to 5.0 mm - fluid-filled microvacuoles that form within the intraocular lens (IOL) optic when the IOL is in an aqueous environment) remains controversial. J Colin and colleagues in Bordeaux, France evaluated the incidence of glistenings in a large series of consecutive eyes implanted with a blue light-filtering hydrophobic IOL. This study included 111 eyes of 74 patients (age range 33 to 86 years). All cases had cataract surgery with AcrySof SN60WF monofocal IOL implantation and had a routine postoperative examination between March 2011 and June 2011. Glistenings occurred in 96 eyes (86.5 per cent). Glistenings were of grade 1 severity in 45 eyes (40.5 per cent) and of grade 2 severity in 51 eyes (45.9 per cent). The follow-up was significantly longer in eyes with grade 2 glistenings. A limited, but significant, correlation was found between glistening severity and length of follow-up. Although there was a trend toward decreased visual acuities at higher glistening grades, there were no significant differences in CDVA between the glistening severity groups.
J Colin et al, JCRS, “Incidence of glistenings with the latest generation of yellow-tinted hydrophobic acrylic intraocular lensesâ€, Volume 38, Issue 7, 1140-1146.Â
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.